This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Thomas Rölle: Innovator in Integrin Antagonists
Introduction
Thomas Rölle is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Thomas Rölle holds a patent for β-amino acid compounds as integrin antagonists. This innovation is crucial for advancing treatments in various medical conditions, showcasing his expertise in the field.
Career Highlights
Rölle is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on innovative research and development, contributing to the company's reputation for excellence.
Collaborations
Throughout his career, Thomas Rölle has collaborated with esteemed colleagues, including Karl Ziegelbauer and Thomas Lehmann. These partnerships have fostered a collaborative environment that enhances the quality of research and innovation.
Conclusion
Thomas Rölle's contributions to the field of integrin antagonists exemplify his dedication to innovation and research. His work continues to impact the pharmaceutical industry positively.